A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

The interaction of rhodium(II) carboxylates with enzymes. (1/1023)

The effect of rhodium(II) acetate, propionate, and methoxyacetate on the activity of 17 enzymes was evaluated. The enzymes were preincubated with the rhodium(II) complexes in order to detect irreversible inhibition. All enzymes that have essential sulfhydryl groups in or near their active site were found to be irreversibly inhibited. Those enzymes without essential sulfhydryl groups were not affected. In each case, the rate of inactivation closely paralleled the observed toxicity and antitumor activity of rhodium(II) carboxylates; that is, rhodium(II) propionate greater than rhodium(II) acetate greater than rhodium(II) methoxyacetate. In addition, those enzymes that have been demonstrated to be most sensitive to established sulfhydryl inhibitors, such as glyceraldehyde-3-phosphate dehydrogenase, were also most sensitive to rhodium(II) carboxylate inactivation. Proton nuclear magnetic resonance measurements made during the titration of rhodium(II) acetate with cysteine showed that breakdown of the carboxylate cage occurred as a result of reaction with this sulfhydryl-containing amino acid.  (+info)

Action of partially thiolated polynucleotides on the DNA polymerase alpha from regenerating rat liver. (2/1023)

The effects of partially thiolated polynucleotides on the DNA polymerase alpha from regenerating rat liver were investigated. The enzyme was isolated from the nuclear fraction essentially according to the method of Baril et al.; it was characterized as the alpha polymerase on the basis of its response to synthetic templates and its inhibition with N-ethylmaleimide. Although polycytidylic acid had no effect on the DNA polymerase alpha either as a template or as an inhibitor, partially thiolated polycytidylic acid (MPC) was found to be a potent inhibitor, its activity being directly related to its extent of thiolation (percentage of 5-mercaptocytidylate units in the polymer). In comparison, the DNA polymerase beta which was purified from normal rat liver nuclear fraction, was much less sensitive to inhibition by MPC. Analysis of the inhibition of the alpha polymerase by the method of Lineweaver and Burk showed that the inhibitory action of MPC was competitively reversible with the DNA template, but the binding of the 7.2%-thiolated MPC to the enzyme was much stronger than that of the template (Ki/Km less than 0.03). Polyuridylic acid as such showed some inhibitory activity which increased on partial thiolation, but the 8.4%-thiolated polyuridylic acid was less active than the 7.2% MPC. When MPC was annealed with polyinosinic acid, it lost 80% of its inhibitory activity in the double-stranded configuration. However, 1 to 2%-thiolated DNA isolates were significantly more potent inhibitors than were comparable (1.2%-thiolated) MPC and showed competitive reversibility with the unmodified (but "activated") DNA template. These results indicate that the inhibitory activities of partially thiolated polynucleotides depend not only on the percentage of 5-mercapto groups but also on the configuration, base composition, and other specific structural properties.  (+info)

Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells. (3/1023)

A monoclonal antibody (mAb; A10) raised against murine Ehrlich tumor cell surface carbohydrates was tested for reactivity with human normal and malignant tissues. A10 reacted strongly, with a high proportion of adenocarcinomas arising from colon and other tissues but not with breast carcinomas or other malignant tumors. Normal tissues were virtually A10 unreactive, except for the duct cells from breast and pancreas and some bronchial mucosae. Ultrastructural studies showed mAb A10 immunolabeling of both microvilli and mucin droplets in colon cancer cells but not in normal absorptive or globet cells. A10 reacted strongly with mucin-enriched fractions from colon cancer tissues and HT-29 xenografts but not from normal colon tissues. A10 epitope was carried on MUC1 derived from colon adenocarcinomas and probably on other mucin species, although not on MUC2 molecules. A10 epitope was resistant to exoglycosidases and periodate oxidation but sensitive to the Smith's degradation and beta-elimination, suggesting the involvement of O-linked carbohydrates in nonterminal reducing positions. A mucin-type glycosidic linkage was supported because of the lack of A10 reactivity with HT-29 cells grown with phenyl-N-acetyl-alpha-D-galactosaminide. Deglycosylation studies with trifluoromethanesulfonic acid pointed to the involvement of core mucin glycans in the A10 epitope. This epitope was resistant to protease, O- and N-glycanase treatments carried out on trifluoromethanesulfonic acid-deglycosylated mucins. Inhibition studies with core 1, core 2, core 3, and core 6 suggested the latter [GlcNAcbeta(1-6)GalNAc] as being involved in A10 epitope. Taken together, the present results point to A10 defining a core 6-related epitope on core mucin glycans expressed by colon cancer MUC1 not previously associated with human cancer.  (+info)

Phospholipid metabolism in ehrlich ascites tumor cells. II. Turnover rate of ether phospholipids. (4/1023)

1. Radioactive precursors of phospholipids, i.e., 32Pi, [1-14C]glycerol, [2-3H]glycerol, and [1-14C]acetate, were individually injected into the peritoneal cavity of mice bearing Ehrlich ascites tumor cells and the rates of incorporation were estimated. 2. Although [2-3H]glycerol was not practically incorporated into ether phospholipids, the other three radioactive precursors were incorporated into diacyl, 1-O-alkenyl-2-acryl-, and 1-O-alkyl-2-acryl-GPE (GPC). 3. In the experiments on 32Pi or [1-14C]acetate incorporation, 1-O-alkyl compounds in the ethanolamine phosphoglyceride fraction showed high specific activities in comparison with 1-acyl compounds. In the case of [1-14C]glycerol incorporation, a high rate of incorporation into 1-O-alkyl compounds was not found. In the choline phosphoglyceride fraction, a high rate of incorporation of the above precursors into 1-O-alkyl compounds was not observed. 4. The specific activities of 1-O-alkenyl compounds were fairly low compared with those of 1-acyl- and 1-O-acyl- and 1-O-alkyl compounds throughout the incorporation experiments with [1-14C]glycerol and [1-14C]acetate, but in 32Pi incorporation, 1-O-alkenyl compounds showed higher specific activities than 1-acyl compounds in ethanolamine phosphoglyceride, suggesting an exchange reaction of the phosphorylethanolamine moiety. 5. From the above findings, it appears that alkyl ether phospholipids of ethanolamine from may have a significant role in ascites tumor cells, based on their rapid turnover.  (+info)

Isolation of ekatetrone, a new metabolite of producing variants of Streptomyces aureofaciens. (5/1023)

From a mixture of substances formed by producing strains of Streptomyces aureofaciens under conditions of submerged fermentation a new metabolite, ekatetrone, was isolated. Its isolation and basic physical and chemical data are described. Ekatetrone is a quinone derivative with a carboxamide group. In tests in vitro with cells of Ehrlich's ascites tumour evidence was provided that ekatetrone inhibits proteo- and nucleosynthesis.  (+info)

New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies. (6/1023)

A new semisynthetic anti-tumour bis-indol compound, KAR-2 [3'-(beta-chloroethyl)-2',4'-dioxo-3,5'-spiro-oxazolidino-4-dea cetoxy-vinblastine] with lower toxicity than vinca alkaloids used in chemotherapy binds to calmodulin but, in contrast to vinblastine, does not exhibit anti-calmodulin activity. To investigate whether the modest chemical modification of bis-indol structure is responsible for the lack of anti-calmodulin potency and for the different pharmacological effects, new derivatives have been synthesized for comparative studies. The synthesis of the KAR derivatives are presented. The comparative studies showed that the spiro-oxazolidino ring and the substitution of a formyl group to a methyl one were responsible for the lack of anti-calmodulin activities. The new derivatives, similar to the mother compounds, inhibited the tubulin assembly in polymerization tests in vitro, however their inhibitory effect was highly dependent on the organization state of microtubules; bundled microtubules appeared to be resistant against the drugs. The maximal cytotoxic activities of KAR derivatives in in vivo mice hosting leukaemia P388 or Ehrlich ascites tumour cells appeared similar to that of vinblastine or vincristine, however significant prolongation of life span could be reached with KAR derivatives only after the administration of a single dose. These studies plus data obtained using a cultured human neuroblastoma cell line showed that KAR compounds displayed their cytotoxic activities at significantly higher concentrations than the mother compounds, although their antimicrotubular activities were similar in vitro. These data suggest that vinblastine/vincristine damage additional crucial cell functions, one of which could be related to calmodulin-mediated processes.  (+info)

Heterogeneity of native ribosomal 60-S subunits in Ehrlich ascites tumor cells cultured in vitro. (7/1023)

Native large ribosomal subunits in cultured Ehrlich ascites tumor cells analyzed by high-resolution CsCl isopycnic centrifugation consist of at least two classes of particles with densities of 1.57 g/cm3 (LI) and 1.59 g/cm3 (LII), respectively. A wash with 0.5 M KCl converts LI into particles with the density of LII particles. Incubation of derived large subunits (density 1.59 g/cm3) with 0.5 M KCl wash of reticulocyte ribosomes leads to the formation of particles with the density of LI particles. A protein with a molecular weight of 57000 present in the high-KCl wash of 60-S native subunits was virtually absent in the KCl wash of 40-S subunits or polyribosomes suggesting that specific protein factors may be present on some native 60-S subunits. Possible functions of these protein factors are discussed.  (+info)

Glyceraldehyde-3-phosphate dehydrogenase from Ehrlich ascites carcinoma cells its possible role in the high glycolysis of malignant cells. (8/1023)

Glyceraldehyde-3-phosphate dehydrogenase has been purified to apparent homogeneity from Ehrlich ascites carcinoma (EAC) cells. The enzyme is quite active over a pH range of 7.5-9.0 with an optimum pH of 8.4-8.7. The specific activity of the enzyme is much higher than that from other normal sources. In contrast to enzyme obtained from rabbit muscle, the EAC cell enzyme is not significantly inhibited by physiological concentrations of ATP at physiological pH. Kinetic studies using different substrates and inhibitors indicate that the properties of the EAC cell enzyme are significantly different from those of glyceraldehyde-3-phosphate dehydrogenase obtained from other normal sources. The striking dissimilarity of the malignant cell glyceraldehyde-3-phosphate dehydrogenase compared with this enzyme from other normal sources, particularly in respect to the interaction with ATP, may in part explain the high glycolysis of malignant cells.  (+info)

I'm sorry for any confusion, but "Carcinoma, Ehrlich Tumor" is not a recognized medical term or a valid medical definition. The term "Ehrlich tumor" is sometimes used to refer to a type of transplantable tumor that was first developed by the German physician Paul Ehrlich in the early 20th century for cancer research purposes. However, it's important to note that this type of tumor is not a naturally occurring cancer and is typically used only in laboratory experiments.

Carcinoma, on the other hand, is a medical term that refers to a type of cancer that starts in cells that line the inner or outer surfaces of organs. Carcinomas can develop in various parts of the body, including the lungs, breasts, colon, and skin.

If you have any specific questions about cancer or a particular medical condition, I would be happy to try to help answer them for you.

Ehrlich-Lettre ascites carcinoma (EAC) is also known as Ehrlich cell. It was originally established as an ascites tumor in mice ... The tumor was cultured in vivo, which became known as the Ehrlich cell. After 1948 Ehrlich cultures spread around research ... Dupre, Ann M.; Hempling, H. G. (December 1978). "Osmotic properties of ehrlich ascites tumor cells during the cell cycle". ... "E (Ehrlich-Lettre ascites) ATCC ® CCL-77™ Mus musculus". DuPre, AM; Hempling, HG (1978). "Osmotic properties of ehrlich ascites ...
"Sacharose density gradient separation of Ehrlich ascites carcinoma and L-5178Y tumor cells in different cell cycle phases". ... Interference of Bruneomycin with the Cell Cycle of Ehrlich's Ascites Carcinoma]. Biológia (in Slovak). 35 (12): 875-80. ... Horáková, K (1975). "Ribonucleases in mouse Ascitic Tumor Cells during Ageing in Vivo and in Vitro". Cell Impairment in Aging ... Horáková, K (1972). "Polynucleotidases in mouse ascitic tumour cells". Neoplasma. 19 (5): 459-68. PMID 4345214. Fuska, JAN; ...
"Immunomodulatory and anti-tumor effects of Nigella glandulifera freyn and sint seeds on ehrlich ascites carcinoma in mouse ... macrophage function and NK anti-tumor activity". Journal of Ethnopharmacology. 131 (2): 268-275. doi:10.1016/j.jep.2010.06.030 ...
This property might be due to an acidic polypeptide found in its leaves that inhibited growth of Ehrlich ascites carcinoma ... In folk medicine, it is used to combat tumors. ...
Mady, E. A. (2002). "Antitumor and biochemical effects of Echis coloratus crude venom on Ehrlich ascites carcinoma cells in ... "Role of dietary magnesium and/or manganese variables on ehrlich ascites tumor‐bearing mice". Nutrition and Cancer. 12 (3): 279- ... "Antitumor Activities of Iodoacetate and Dimethylsulphoxide Against Solid Ehrlich Carcinoma Growth in Mice". Biological Research ...
Ehrlich carcinoma and Crocker sarcoma of mice and the Walker carcinoma of rats. He was aware that precision drugs would be ... even if the tumor cannot be completely eliminated. We will be satisfied if we ca slow down it growth, in order to preserve the ... Later, Ehrlich and his students found that some azo dyes were effective against African sleeping sickness. In 1913, P. ... For example, German biologist Paul Ehrlich used methylene blue, a type of azo dye, to kill malarial parasites in experimental ...
"Antitumor Activities of Iodoacetate and Dimethylsulphoxide Against Solid Ehrlich Carcinoma Growth in Mice". Biological Research ... Apffel, C. A.; Arnason, B. G.; Peters, J. H. (1966). "Induction of tumour immunity with tumour cells treated with iodoacetate ... In 1966 Charles A. Apffel, Barry G. Arnason & John H. Peters showed anti-tumor activity for iodoacetate. Iodide is a naturally ... Several studies have shown iodoacetate has anti-tumor effects. In 2002 Fawzia Fahim showed that "a single IAA treatment of ...
"Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma". Journal of ... the 2017 Paul Ehrlich and Ludwig Darmstaedter Prize and the 2017 Passano Award. They are 2017 Clarivate Citation Laureates. " ... In 1994, they discovered a new human herpesvirus, KSHV, in a KS tumor and along with several collaborators showed that it was ... His laboratory currently seeks to understand the role of tumor virus immunoevasion of the innate immune system as a cause for ...
His discovery of erbB2 as a v-erbB-related gene amplified in a human breast carcinoma and the demonstration of its transforming ... Current research includes investigations into the mechanisms by which tumor suppressor genes induce permanent growth arrest/ ... 1982 Rhoads Memorial Award 1982 PHS Meritorious Service Medal 1989 Paul Ehrlich Award 1989 PHS Distinguished Service Medal 1990 ... "Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma". ...
"Withaferin A suppresses the expression of vascular endothelial growth factor in Ehrlich ascites tumor cells via Sp1 ... September 2003). "Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter". ...
These effects seem to be largely mediated by mutations at guanine in codon 249 of the p53 gene, a tumor suppressing gene, and ... Prevalence of hepatocellular carcinoma in individuals exposed to aflatoxin, increases with co-infection of hepatitis B virus. ... Yu J, Chang PK, Ehrlich KC, et al. (March 2004). "Clustered pathway genes in aflatoxin biosynthesis". Appl. Environ. Microbiol ... Up to 44% of hepatocellular carcinomas in regions with high aflatoxin exposure bear a GC → TA transversion at codon 249 of p53 ...
... carcinoma, ehrlich tumor MeSH C04.557.470.200.220 - carcinoma, giant cell MeSH C04.557.470.200.240 - carcinoma in situ MeSH ... carcinoma, signet ring cell MeSH C04.557.470.200.025.415.410 - krukenberg tumor MeSH C04.557.470.200.025.420 - carcinoma, skin ... sertoli-leydig cell tumor MeSH C04.557.475.750.847.249 - leydig cell tumor MeSH C04.557.475.750.847.500 - sertoli cell tumor ... carcinoma, large cell MeSH C04.557.470.200.280 - carcinoma, lewis lung MeSH C04.557.470.200.300 - carcinoma, non-small-cell ...
Since the late 1970s, Rammensee has been focusing on immunology with the specific aim of using tumor immunology to fight ... 2013 Paul Ehrlich and Ludwig Darmstaedter Prize, 1996 Robert Koch Prize, 1993 Gottfried Wilhelm Leibniz Prize, 1992 Heinz Maier ... The immunopeptidomic landscape of ovarian carcinomas. Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951. doi: 10.1073/ ... Rammensee has contributed essentially to the research fields of MHC biology and tumor immunology and to the development of ...
... but is significantly focally deleted across the entire dataset of 3131 tumors, suggesting that IRF8 is potentially a tumor ... Sharf R, Azriel A, Lejbkowicz F, Winograd SS, Ehrlich R, Levi BZ (June 1995). "Functional domain analysis of interferon ... Molecular analysis indicated that the IRF8 gene promoter is hypermethylated in human colon carcinoma cells, suggesting that ... Sharf R, Azriel A, Lejbkowicz F, Winograd SS, Ehrlich R, Levi BZ (1995). "Functional domain analysis of interferon consensus ...
"Characterization of the cell-cycle-regulated protein calcyclin from Ehrlich ascites tumor cells. Identification of two binding ... S100A6 to be reported as possible diagnostic marker of papillary thyroid carcinoma. GRCh38: Ensembl release 89: ENSG00000197956 ... "Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid ... carcinoma". Thyroid. 20 (10): 1067-76. doi:10.1089/thy.2009.0400. PMID 20629554. Schäfer BW, Heizmann CW (1996). "The S100 ...
MSI-L tumors result from less than 30% of unstable MSI biomarkers. MSI-L tumors are classified as tumors of alternative ... MSI has been evident in the cause of sebaceous carcinomas. Sebaceous carcinomas are a subset of a larger pathology, Muir-Torre ... Ehrlich M, ed. (2000). DNA alterations in cancer: genetic and epigenetic changes. Natick, MA: Eaton Publ. p. 178. ISBN 978-1- ... MSI tumors in 15% of sporadic colorectal cancer result from the hypermethylation of the MLH 1 gene promoter, whereas MSI tumors ...
... the two decided to look at fine structures within the cells of the Ehrlich ascites carcinoma, a commonly used model for cancer ... "The Coming of Age of Tumor Virology." Cancer Research 37 (1977): 1255-1263 "Hemoglobin Synthesis in Murine Virus-induced ...
... the ability for FGF8 to regulate cell proliferation has caused interest in its effects on tumors or squamous cell carcinoma. ... Gemel J, Gorry M, Ehrlich GD, MacArthur CA (July 1996). "Structure and sequence of human FGF8". Genomics. 35 (1): 253-7. doi: ... Overexpression of this gene has been shown to increase tumor growth and angiogenesis. The adult expression of this gene was ... This protein is known to be a factor that supports androgen and anchorage independent growth of mammary tumor cells. ...
Hepatitis C virus core variants isolated from liver tumor but not from adjacent non tumor interact with Smad3 and inhibit the ... doi: 10.1002/hep.24087 Arumugam M, Raes J, Brechot C, Merieux A, Weissenbach J, Ehrlich SD, Bork P. Enterotypes of the human ... hepatocellular carcinoma, HCC), as well as the molecular mechanisms underpinning liver regeneration and cancer (especially the ... Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. ...
"Renal cell carcinoma antigen is expressed by yolk sac tumors and yolk sac elements of embryonal carcinomas". Applied ... Grunau C, Sanchez C, Ehrlich M, van der Bruggen P, Hindermann W, Rodriguez C, Krieger S, Dubeau L, Fiala E, De Sario A (May ... Götte K, Usener D, Riedel F, Hörmann K, Schadendorf D, Eichmüller S (July 2002). "Tumor-associated antigens as possible targets ... "Entrez Gene: RAGE renal tumor antigen". Eichmüller S, Usener D, Jochim A, Schadendorf D (August 2002). "mRNA expression of ...
It is suggested that this gene may itself be a tumor suppressor acting in the same pathway as BRCA1. Three transcript variants ... Germani A, Prabel A, Mourah S, Podgorniak MP, Di Carlo A, Ehrlich R, Gisselbrecht S, Varin-Blank N, Calvo F, Bruzzoni- ... in breast carcinomas". Int. J. Cancer. 107 (1): 155-8. doi:10.1002/ijc.11343. PMID 12925972. S2CID 20908722. Dick FA, Sailhamer ... "The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity". J. ...
"Prize Winners of the Paul Ehrlich and Ludwig Darmstaedter Prize" (PDF). uni-frankfurt.de. The Paul Ehrlich Foundation. ... M Dürst; L Gissmann; H Ikenberg; H zur Hausen (1 June 1983). "A papillomavirus DNA from a cervical carcinoma and its prevalence ... A History of Tumor Virology. Baltimore: Johns Hopkins University Press. ISBN 9781421444017. OCLC 1276804549. Wikimedia Commons ... Paul Ehrlich and Ludwig Darmstaedter Prize (1994) International member of the American Philosophical Society (1998) Raymond ...
... of AP-1 repressor JDP2 is associated with tumor metastasis and poor prognosis in patients with pancreatic carcinoma". The ... Ji H, Ehrlich LI, Seita J, Murakami P, Doi A, Lindau P, et al. (September 2010). "Comprehensive methylome map of lineage ... JDP2 shows the gene amplification of head and neck squamous-cell carcinoma. In pancreatic carcinoma, downregulation of JDP2 is ... July 2005). "Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus". Virology. 337 (2): 353-364. doi ...
It is now believed that the Kaiser had hybrid verrucous carcinoma, a very rare form of verrucous carcinoma, and that Virchow ... Experiments also show that drugs that block inflammation simultaneously inhibit tumour formation and development. Virchow was ... and that of Paul Ehrlich, who studied at the Charité while Virchow was developing microscopic pathology there. One of Virchow's ... Metastasis was first described by Karl Thiersch in the 1860s.) He made a crucial observation that certain cancers (carcinoma in ...
... the Brown-Pearce Carcinoma. They studied transmission of the tumor by inoculating a series of more than twenty other rabbits, ... Building on the work of Paul Ehrlich in Germany, who had developed an arsenic-derived drug called Salvarsan for the treatment ... While the fundamental nature of the tumor remained the same, its malignancy varied. They attempted to understand the ... Because it was thoroughly studied, and replicable, the Brown-Pearce tumor became a standard test material in cancer ...
... (September 11, 1904 - July 19, 1999) was a Polish-American virologist who discovered two different tumor viruses- ... Principal 1978 Paul Ehrlich-Ludwig Darmstaeder Prize in Frankfurt Griffuel Prize in Paris (1978) Elected to the National ... murine polyomavirus is closely related to the human Merkel cell polyomavirus that causes most forms of Merkel cell carcinoma. ...
"Prize Winners of the Paul Ehrlich and Ludwig Darmstaedter Prize" (PDF). The Paul Ehrlich Foundation. Retrieved 17 October 2022 ... The first analyzed tumors included those of the colon, breast, pancreas, and brain. These studies outlined the landscapes of ... April 1989). "Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas". Science. 244 (4901): 217-21. Bibcode: ... The Paul Ehrlich and Ludwig Darmstaedter Prize from the Paul Ehrlich Foundation 1998 - The William Allan Award from the ...
In ovarian cancer, p27 negative tumors progressed in 23 months compared to 85 months in p27 positive tumors and thus could be ... In hepatocellular carcinoma cells p27 co-localizes with actin fibers to act on GTPase Rac and induce cell migration. In breast ... Liu X, Sun Y, Ehrlich M, Lu T, Kloog Y, Weinberg RA, Lodish HF, Henis YI (November 2000). "Disruption of TGF-beta growth ... In most cancers reduced levels of nuclear p27 are correlated with increased tumor size, increased tumor grade, and a higher ...
... monophosphate from orotate in Ehrlich ascites carcinoma. Purification by tandem affinity chromatography of uridine-5'- ... "Orotate phosphoribosyltransferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracil". ... "Effect of 5-phosphoribosyl-a-pyrophosphate on de novo pyrimidine biosynthesis in cultured Ehrlich ascites cells made permeable ... phosphate decarboxylase enzyme complex from mouse Ehrlich ascites cells". The Journal of Biological Chemistry. 254 (4): 1143-50 ...
Another tumor-lysing virus that specifically targets tumor cells with an activated Ras pathway is a type II herpes simplex ... Rotblat B, Ehrlich M, Haklai R, Kloog Y (2008). "The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the ... Parada LF, Tabin CJ, Shih C, Weinberg RA (June 1982). "Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ... "Brain tumour findings offer hope of new strategy Canadian Cancer Society says" at ncic.cancer.ca "Novel cancer treatment gets ...
... inhibition of tumor growth and a 3-fold increase in the life span of tumor bearing animals compared to untreated tumor mice. ... Preparation of Ehrlich ascites carcinoma (EAC) cells and induction of tumor development. Ehrlich ascites carcinoma was chosen ... Tumor was induced by injecting Ehrlich ascites carcinoma cells, a breast adenocarcinoma of mouse origin in Swiss albino mice. ... Tumor size was measured using vernier calipers on alternative days for tumor animals and tumor volume was calculated using the ...
Ehrlich-Lettre ascites carcinoma (EAC) is also known as Ehrlich cell. It was originally established as an ascites tumor in mice ... The tumor was cultured in vivo, which became known as the Ehrlich cell. After 1948 Ehrlich cultures spread around research ... Dupre, Ann M.; Hempling, H. G. (December 1978). "Osmotic properties of ehrlich ascites tumor cells during the cell cycle". ... "E (Ehrlich-Lettre ascites) ATCC ® CCL-77™ Mus musculus". DuPre, AM; Hempling, HG (1978). "Osmotic properties of ehrlich ascites ...
Potential anti-tumor activity of kefir-induced juglone and resveratrol fractions against ehrlich ascites carcinoma.Dec 31, 2019 ... A novel kefir product (PFT) inhibits Ehrlich ascites carcinoma in mice via induction of apoptosis and immunomodulation.Apr 27, ... The results suggest that the six lactic acid bacteria mixture from kefir has strong effects on natural immunity and tumor cell ... Pharmacological Actions : Anti-Inflammatory Agents, Interleukin-1 beta downregulation, Tumor Necrosis Factor (TNF) Alpha ...
Cutaneous tumors encompass a vast array of malignancies, from neuroendocrine to lymphoid. In addition to primary malignancies, ... Moyer KE, Banducci DR, Graham WP 3rd, Ehrlich HP. Dupuytrens disease: physiologic changes in nodule and cord fibroblasts ... encoded search term (Merkel Cell Carcinoma and Rare Appendageal Tumors) and Merkel Cell Carcinoma and Rare Appendageal Tumors ... clear cell carcinoma, and mucinous carcinoma. [130] All these tumors have the capacity to metastasize to skin and regional ...
The most common toxicosis was fever (n = 6 dogs). Two dogs developed abscesses (1 within a nasal carcinoma and 1 splenic ... Clinical response was measured by use of response evaluation criteria in solid tumors at 28 days. Results-The first 2 dogs had ... Clostridium novyi-NT was cultured from 1 of 6 tumors. Five dogs were available for response assessment (4 had stable disease; 1 ... Further studies in dogs with superficial tumors may allow for continued dose escalation and provide information for use in ...
Ehrlich ascites carcinoma (EAC) cells were administered into the mice by subcutaneous injection. Animals with solid tumors were ... Inhibition of Ehrlich ascites carcinoma growth by melatonin: Studies with micro-CT SEHER YILMAZ1,2,*, ZÜLEYHA DOĞANYIĞIT3, MERT ...
Allyl isothiocyanate inhibited the growth of Ehrlich ascites tumor in mice by proapoptotic and antiangiogenic mechanisms [29]. ... NSCLCs include diverse types of carcinomas, such as large-cell carcinomas, squamous cell carcinomas, and adenocarcinomas [3]. ... Tumor metastasis is a detrimental consequence of tumor burden; therefore, extensive efforts have been made to identify novel ... Das, A.K.; Bell, M.H.; Nirodi, C.S.; Story, M.D.; Minna, J.D. Radiogenomics predicting tumor responses to radiotherapy in lung ...
30.0 mg/kg metoclopramide or 4.0 mg/kg domperidone on the number of tumor cells of mice bearing Ehrlich ascites carcinoma. The ... 4.0 mg/kg bromocriptine or 2.0 mg/kg amphetamine on the number of tumor cells of mice bearing Ehrlich ascites carcinoma. the ... ANTITUMOR EFFECTS OF DOPAMINERGIC BLOCKERS IN MICE BEARING EHRLICH TUMORS  Frussa-Filho, Roberto [UNIFESP]; Soares, CGC; Decio ... EFFECTS of HALOPERIDOL, BROMOCRIPTINE and AMPHETAMINE ON the DEVELOPMENT of EHRLICH ASCITES-CARCINOMA in MICE  Frussa, R.; ...
... mammary carcinoma E0771, Taper liver tumor, Ehrlich carcinoma (solid and ascites), and Walker carcinosarcoma 256. Not effective ... DMBA-induced rat mammary carcinoma and the following transplanted experimental tumors: sarcoma 180, plasma cell tumor LPC-1, ... Three transplantable rodent tumors (osteogenic sarcoma, Lewis lung carcinoma, and P388 leukemia). No antitumor activity at 20% ... Additional cell culture and animal studies involving more than a dozen other tumor models have been published.[1,4,6,8,9,14,15 ...
Magnetite nanoparticles inhibit tumor growth and upregulate the expression of p53/p16 in Ehrlich solid carcinoma bearing mice. ... The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL- ... Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein. Sci Transl Med. 2012;4: ... MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in ...
Pineapple bromelain has anti-tumor properties superior to the chemo-agent 5-fluorouracil. ... Ehrlich ascitic tumor (EAT), Lewis lung carcinoma (LLC), MB-F10 melanoma and ADC-755 mammary adenocarcinoma. Intraperitoneal ... The antitumoral activity of bromelain against S-37 and EAT, which are tumor models sensitive to immune system mediators, and ... With the exception of MB-F10 melanoma, all other tumor-bearing animals had a significantly increased survival index after ...
Antitumor potential of Citrus limetta fruit peel in Ehrlich ascites. carcinoma bearing Swiss albino mice*. Authors: Sriparna ... On the 10th day, half of the mice were sacrificed for the estimation of tumor growth (tumor volume, viable and non-viable tumor ... decrease in tumor volume, viable tumor cell count, tumor weight and a significant (P,0.001) improvement in hematological ... The present study establishes marked and dose dependant anti-tumor effect of C. limetta fruit peel against Ehrlich ascites ...
Transdermal Delivery of 5-Fluorouracil for Induced Ehrlich Ascites Carcinoma Tumor in Balb/c Mice and Pharmacokinetic Study. ...
... in vivo antitumor activity using Ehrlich ascites carcinoma (EAC) tumor model. (36). • Cytotoxicity / Human Colorectal Carcinoma ... The alkaloid has growth inhibition effects to some human tumors. Vinblastine is used experimentally for treatment of neoplasms ... Vincristine from CrP14 / Apoptosis in Human Squamous Carcinoma A431: Previous study reported that Eutypella spp.-CrP14 isolated ... Fungal vincristine from Eutypella spp.- CrP14 isolated from Catharanthus roseus induces apoptosis in human squamous carcinoma ...
Immunomodulatory and anti-tumor effects of Nigella glandulifera freyn and sint seeds on ehrlich ascites carcinoma in mouse ... Immunomodulatory and anti-tumor effects of Nigella glandulifera freyn and sint seeds on ehrlich ascites carcinoma in mouse ... more about Immunomodulatory and anti-tumor effects of Nigella glandulifera freyn and sint seeds on ehrlich ascites carcinoma in ...
The effect of vitamin B17 on Cardiomyopathy against Ehrlich Tumor Development in Female mice. Biochem Lett. 2021;17:69-76. ... Molecular imaging of tumor microenvironment to assess the effects of locoregional treatment for hepatocellular carcinoma. ... The most common malignant tumor, hepatocellular carcinoma (HCC), arises from well-differentiated hepatocytes [1]. It is the ... Current Understandings of the Modern Therapeutic Approaches for Hepatocellular Carcinoma. in Phytochemicals Targeting Tumor ...
ginger oil, nanoemulsion, Ehrlichs ascites carcinoma, apoptosis, tumor, breast cancer, Chemical technology, and TP1-1185 ... 4. Ginger Oil Nanoemulsion Formulation Augments Its Antiproliferative Effect in Ehrlich Solid Tumor Model [2023] ... Notably, tumor infiltration of the optic nerve tends to result in more profound visual impairment compared to papilledema due ... activity of the best nano-formulation was determined in comparison with the free oil using the in vivo Ehrlich solid tumor (EST ...
... and Ehrlich Ascites Carcinoma (EAC) bearing mice and reduced the volume of transplanted solid tumours. The extract inhibited ... exhibited potent anticarcinogenic activity against 20-methylcholanthrene induced sarcoma and increased the survival of tumour ... An aqueous extract on human hepatocellular carcinoma derived cell at 1 mg mL-1 concentration on a single dose. Inhibition of ...
Antitumor and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo. Acta Oncol. 1996;35:95-100. ... on a transplantable mouse tumor, Sarcoma-180. Indian J Exp Biol. 1993;31:607-611. View abstract. ... In vivo growth inhibitory and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma. Cancer Lett. 8-16- ... on a transplantable mouse tumor, Sarcoma 180. Indian J Exp Biol. 1992;30:169-172. View abstract. ...
Ehrlich Tumor Carcinoma Medicine & Life Sciences 100% * RNA Polymerase II Medicine & Life Sciences 84% ... A protein factor named S-I(b) that stimulates the activity of RNA polymerase II was purified from Ehrlich ascites tumor cells. ... N2 - A protein factor named S-I(b) that stimulates the activity of RNA polymerase II was purified from Ehrlich ascites tumor ... AB - A protein factor named S-I(b) that stimulates the activity of RNA polymerase II was purified from Ehrlich ascites tumor ...
Action of deoxyribonuclease and ribonuclease on the growth of Ehrlich ascites carcinoma in mice ... Many tumor cells arrested on endothelial cells. B, DNase I-treated case (0. 1 U per mouse). The number of tumor cells is ... Many tumor cells arrested on endothelial cells. B, DNase I-treated case (0. 1 U per mouse). The number of tumor cells is ... carried out direct tests to measure the effect of DNase and RNase on cancer in mice using Ehrlich ascites carcinoma as a model ...
Ehrlich-Lettre ascites carcinoma (EAC) is also known as Ehrlich cell. It was originally established as an ascites tumor in mice ... An experimental study of Ehrlichs ascetic carcinoma in Swiss albino mice with chemotherapy Authors. * Utpal Goswami ICARE ... 2020). An experimental study of Ehrlichs ascetic carcinoma in Swiss albino mice with chemotherapy. Asian Pacific Journal of ... Ehrlichs ascetic carcinoma, Swiss albino mice, Chemotherapy, Actinomycin D, Survival Abstract. Background: ...
Cutaneous tumors encompass a vast array of malignancies, from neuroendocrine to lymphoid. In addition to primary malignancies, ... Moyer KE, Banducci DR, Graham WP 3rd, Ehrlich HP. Dupuytrens disease: physiologic changes in nodule and cord fibroblasts ... encoded search term (Merkel Cell Carcinoma and Rare Appendageal Tumors) and Merkel Cell Carcinoma and Rare Appendageal Tumors ... Eccrine carcinoma. Primary eccrine carcinomas are rare malignant tumors with variable histologic forms, including eccrine ...
Ehrlich ascitic tumor (EAT), Lewis lung carcinoma (LLC), MB-F10 melanoma and ADC-755 mammary adenocarcinoma - along with 5- ... The use of bromelain in cancer has its roots in a laboratory study of several tumor cell lines - P-388 leukemia, sarcoma (S-37 ... The antitumoral activity of bromelain against S-37 and EAT, which are tumor models sensitive to immune system mediators, and ... With the exception of MB-F10 melanoma, all other tumor-bearing animals had a significantly increased survival index after ...
... at a total dose of 80 Gy and neutrons at a dose of 5 Gy on the tumor response of the solid form of Ehrlich ascites carcinoma ( ... sequence of neutron and proton radiations on the tumor response and skin reactions under irradiation of solid Ehrlich carcinoma ... Since the palpable volume of the tumor was comparable with the size of the paw, and the tumor node was close to the skin, the ... In the "neutrons" group, the delay of tumor growth induction was observed for 15 days in all animals, but then the tumor growth ...
Besides, 8e was evaluated for its in vivo antitumor activity using solid Ehrlich carcinoma. The reduction in both the tumor ... The prepared compounds 5a-p were inspected for their in vitro anti-tumor activity at NCI-DTP and subsequently 5h was selected ... Firstly, all target isatins were examined for in vitro antitumor action on NCI-USA panel (58 tumour cell lines). Then, the most ... MBFS (11b and 17) and BBFS (28b, 29a and 30) efficiently inhibited the tumor-related CA IX isoform in the single-digit ...
... and Ehrlich Ascites Carcinoma. (EAC) were maintained in the peritoneal cavity of Swiss albino mice as. ascites tumour. Ascites ... tumour volume of the tumour bearing animals. This increase in life span. or survival rate and decrease in tumour volume of LWA ... In vivo tumour study revealed that LWA treatment significantly reduced tumour growth and. improved survival in DLA tumour ... 6. Effects of LWA treatment on the tumour growth of DLA solid tumour bearing animals. a) Representative images of DLA tumour ...
EHRLICH ASCITES-Evaluation of antitumor activity of Cuscuta reflexa Roxb (Cuscutaceae) against Ehrlich ascites carcinoma in ... ANTI-TUMOR:. -Chatterjee et al. Evaluation of Antitumor Activity of Cuscuta Reflexa Roxb (Cuscutaceae) Against Ehrlich Ascites ... fresh herb is beaten and applied to Scrofulous tumors. (Grieves). -herb is fried in oil and made into a paste for chronic ... opens obstructions of the Spleen, clears Black Jaundice, good for Scabs, Ulcers, Leprosy, hard Tumors from Melancholy.. - ...
Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice. ... Tumor. 2000;86:157-162.. *Oz E, Ilhan MN. Effects of melatonin in reducing the toxic effects of doxorubicin. Mol Cell Biochem. ... and also can help kill melanoma tumors and help stop them from spreading. See below for a... ...
On Day 8, mice bearing a solid Ehrlich carcinoma (SEC) tumor were treated with MGN-3 via intraperitoneal injection. Tumor ... In Vivo Tumor Inhibitory Effects of Nutritional Rice Bran Supplement MGN-3/Biobran on Ehrlich Carcinoma-Bearing Mice PEER ... Background: Metastatic hepatocellular carcinoma often has a multifocal tumor pattern with markedly depressed hepatic function, ... Arabinoxylan rice bran (MGN-3/Biobran) enhances radiotherapy in animals bearing Ehrlich ascites carcinoma This study examines ...

No FAQ available that match "carcinoma ehrlich tumor"

No images available that match "carcinoma ehrlich tumor"